Stock Analysis

Zhuzhou Huarui Precision Cutting ToolsLtd Third Quarter 2024 Earnings: EPS: CN¥0.084 (vs CN¥0.70 in 3Q 2023)

Published
SHSE:688059

Zhuzhou Huarui Precision Cutting ToolsLtd (SHSE:688059) Third Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥174.1m (down 25% from 3Q 2023).
  • Net income: CN¥5.12m (down 88% from 3Q 2023).
  • Profit margin: 2.9% (down from 19% in 3Q 2023). The decrease in margin was driven by lower revenue.
  • EPS: CN¥0.084 (down from CN¥0.70 in 3Q 2023).
SHSE:688059 Earnings and Revenue Growth November 1st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Zhuzhou Huarui Precision Cutting ToolsLtd Earnings Insights

Looking ahead, revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Machinery industry in China.

Performance of the Chinese Machinery industry.

The company's shares are down 7.0% from a week ago.

Risk Analysis

Before you take the next step you should know about the 4 warning signs for Zhuzhou Huarui Precision Cutting ToolsLtd (2 can't be ignored!) that we have uncovered.

Valuation is complex, but we're here to simplify it.

Discover if Zhuzhou Huarui Precision Cutting ToolsLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.